BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mahmud KM, Niloy MS, Shakil MS, Islam MA. Ruthenium Complexes: An Alternative to Platinum Drugs in Colorectal Cancer Treatment. Pharmaceutics 2021;13:1295. [PMID: 34452256 DOI: 10.3390/pharmaceutics13081295] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
Number Citing Articles
1 Mambanda A, Ongoma P, Gichumbi J, Omondi RO, Hunter LA, Kanyora AK. Crystal Structures of Half-Sandwich Ru(II) Complexes, [(η6-p-Cymene)(3-chloro-6-(1H-pyrazol-1-yl)pyridazine)Ru(X)]BF4, (X = Cl, Br, I). Molbank 2022;2022:M1477. [DOI: 10.3390/m1477] [Reference Citation Analysis]
2 Caro-Ramírez JY, Rivas MG, Gonzalez PJ, Williams PAM, Naso LG, Ferrer EG. Copper(II) cation and bathophenanthroline coordination enhance therapeutic effects of naringenin against lung tumor cells. Biometals 2022. [PMID: 35931942 DOI: 10.1007/s10534-022-00422-4] [Reference Citation Analysis]
3 Guo W, Ji T, Deng Y, Liu J, Gou Y, Dong W. Facile synthesis of a glutathione-depleting Cu(II)-half-salamo-based coordination polymer for enhanced chemodynamic therapy. Dalton Trans 2022. [PMID: 35876194 DOI: 10.1039/d2dt01786e] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Leskovská J, Miklášová N, Kubelac PM, Achimaş-cadariu P, Valentová J, Markuliak M, Fischer-fodor E. Antiproliferative Ruthenium Complexes Containing Curcuminoid Ligands Tested In Vitro on Human Ovarian Tumor Cell Line A2780, towards Their Capability to Modulate the NF-κBTranscription Factor, FGF-2 Growth Factor, and MMP-9 Pathway. Molecules 2022;27:4565. [DOI: 10.3390/molecules27144565] [Reference Citation Analysis]
5 Teixeira-Guedes C, Brás AR, Teixeira RG, Valente A, Preto A. Ruthenium(II)-Cyclopentadienyl-Derived Complexes as New Emerging Anti-Colorectal Cancer Drugs. Pharmaceutics 2022;14:1293. [PMID: 35745864 DOI: 10.3390/pharmaceutics14061293] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Chen D, Guo S, Tang X, Rong Y, Bo H, Shen H, Zhao Z, Qiao A, Shen J, Wang J. Combination of ruthenium (II) polypyridyl complex Δ-Ru1 and Taxol enhances the anti-cancer effect on Taxol-resistant cancer cells through Caspase-1/GSDMD-mediated pyroptosis. Journal of Inorganic Biochemistry 2022;230:111749. [DOI: 10.1016/j.jinorgbio.2022.111749] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
7 Ferraro MG, Piccolo M, Misso G, Santamaria R, Irace C. Bioactivity and Development of Small Non-Platinum Metal-Based Chemotherapeutics. Pharmaceutics 2022;14:954. [DOI: 10.3390/pharmaceutics14050954] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
8 Juszczak M, Kluska M, Kosińska A, Rudolf B, Woźniak K. Antioxidant Activity of Ruthenium Cyclopentadienyl Complexes Bearing Succinimidato and Phthalimidato Ligands. Molecules 2022;27:2803. [PMID: 35566156 DOI: 10.3390/molecules27092803] [Reference Citation Analysis]
9 Khatkar S, Dubey SK, Saraf P, Bhardwaj JK, Kumar S, Kumar V, Singh G, Shayoraj. Ruthenium(II) dimethyl sulphoxide based complexes: A potent inducer of apoptosis. Results in Chemistry 2022;4:100481. [DOI: 10.1016/j.rechem.2022.100481] [Reference Citation Analysis]
10 Shakil MS, Mahmud KM, Sayem M, Niloy MS, Halder SK, Hossen MS, Uddin MF, Hasan MA. Using Chitosan or Chitosan Derivatives in Cancer Therapy. Polysaccharides 2021;2:795-816. [DOI: 10.3390/polysaccharides2040048] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]